These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22391882)

  • 21. Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndrome.
    Guerra F; Mancinelli L; Buglioni A; Pierini V; Rappelli A; Dessì-Fulgheri P; Sarzani R
    High Blood Press Cardiovasc Prev; 2011 Dec; 18(4):195-201. PubMed ID: 22283674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of metabolic syndrome on hypertension-related target organ damage.
    Mulè G; Nardi E; Cottone S; Cusimano P; Volpe V; Piazza G; Mongiovì R; Mezzatesta G; Andronico G; Cerasola G
    J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients.
    Eguchi K; Kario K; Hoshide S; Ishikawa J; Morinari M; Shimada K
    Am J Hypertens; 2005 Jan; 18(1):23-9. PubMed ID: 15691613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects.
    Mulè G; Nardi E; Cottone S; Cusimano P; Incalcaterra F; Giandalia ME; Palermo A; Mezzatesta G; Cerasola G
    Int J Cardiol; 2007 Oct; 121(3):267-75. PubMed ID: 17258825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of silent myocardial ischemia in resistant hypertensive patients.
    Modolo R; de Faria AP; Paganelli MO; Sabbatini AR; Barbaro NR; Nascimento BB; Ramos CD; Fontana V; Calhoun DA; Moreno H
    Am J Hypertens; 2015 Feb; 28(2):200-7. PubMed ID: 25063735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network.
    Lønnebakken MT; Mancusi C; Losi MA; Gerdts E; Izzo R; Manzi MV; De Luca N; de Simone G; Trimarco B
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):185-190. PubMed ID: 30559043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and reproducibility of differences between home and ambulatory blood pressure and their relation with hypertensive organ damage.
    Gazzola K; Cammenga M; van der Hoeven NV; van Montfrans GA; van den Born BJH
    J Hum Hypertens; 2017 Sep; 31(9):555-560. PubMed ID: 28382957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Office blood pressure, ambulatory blood pressure monitoring, and echocardiographic abnormalities in women with polycystic ovary syndrome: role of obesity and androgen excess.
    Luque-Ramírez M; Martí D; Fernández-Durán E; Alpañés M; Álvarez-Blasco F; Escobar-Morreale HF
    Hypertension; 2014 Mar; 63(3):624-9. PubMed ID: 24324038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension.
    Palatini P; Graniero GR; Canali C; Santonastaso M; Mos L; Piccolo D; D'Este D; Berton G; Zanata G; De Venuto G
    J Hypertens; 1995 Dec; 13(12 Pt 2):1796-800. PubMed ID: 8903654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals.
    Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Zanchetti A
    J Hypertens; 2005 Aug; 23(8):1589-95. PubMed ID: 16003187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of body weight changes on 24-hour blood pressure and left ventricular mass in hypertension: a 4-year follow-up.
    Schillaci G; Pasqualini L; Vaudo G; Lupattelli G; Pirro M; Gemelli F; De Sio M; Porcellati C; Mannarino E
    Am J Hypertens; 2003 Aug; 16(8):634-9. PubMed ID: 12878368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST.
    Palatini P; Mormino P; Dorigatti F; Santonastaso M; Mos L; De Toni R; Winnicki M; Dal Follo M; Biasion T; Garavelli G; Pessina AC;
    Kidney Int; 2006 Aug; 70(3):578-84. PubMed ID: 16788693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of target organ damage and metabolic abnormalities in resistant hypertension].
    Armario P; Oliveras A; Hernández Del Rey R; Ruilope LM; De La Sierra A;
    Med Clin (Barc); 2011 Oct; 137(10):435-9. PubMed ID: 21719041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure and cardiorenal responses to antihypertensive therapy in obese women.
    Rosa EC; Zanella MT; Kohlmann NE; Ferreira SR; Plavnik FL; Ribeiro AB; Kohlmann O
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):65-75. PubMed ID: 18345398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular mass index as a predictor of new-onset microalbuminuria in hypertensive subjects: a prospective study.
    Andrikou E; Tsioufis C; Thomopoulos C; Andrikou I; Kasiakogias A; Leontsinis I; Kordalis A; Katsimichas T; Tousoulis D; Stefanadis C
    Am J Hypertens; 2012 Nov; 25(11):1195-201. PubMed ID: 22932703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project.
    Shantsila A; Lane DA; Beevers DG; Lip GY
    Hypertens Res; 2013 Jun; 36(6):546-9. PubMed ID: 23407241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study).
    Palatini P; Graniero GR; Mormino P; Mattarei M; Sanzuol F; Cignacco GB; Gregori S; Garavelli G; Pegoraro F; Maraglino G; Bortolazzi A; Accurso V; Dorigatti F; Graniero F; Gelisio R; Businaro R; Vriz O; Dal Follo M; Camarotto A; Pessina AC
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):334-41. PubMed ID: 8722436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do Obese Individuals With Hypertension Have More Difficult-to-Control Blood Pressure and End Organ Damage Than Their Nonobese Counterparts?
    Jesky MD; Hayer MK; Thomas M; Dasgupta I
    J Clin Hypertens (Greenwich); 2015 Jun; 17(6):466-72. PubMed ID: 25807883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The white coat effect is not associated with additional increase of target organ damage in true resistant hypertension.
    Figueiredo VN; Martins LC; Boer-Martins L; Cabral de Faria AP; de Haro Moraes C; Cardoso Santos R; Nogueira AR; Moreno H
    Med Clin (Barc); 2013 Jan; 140(1):1-5. PubMed ID: 22995840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.
    Zhang K; Huang F; Chen J; Cai Q; Wang T; Zou R; Zuo Z; Wang J; Huang H
    Medicine (Baltimore); 2014 Nov; 93(25):e130. PubMed ID: 25437025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.